Addiction and the brain antireward system

被引:915
作者
Koob, George F. [1 ]
Le Moal, Michel [2 ]
机构
[1] Scripps Res Inst, Committe Neurol Addict Disorders, La Jolla, CA 92037 USA
[2] Univ Bordeaux 2, Unite 862, Inst Natl Sante & Rech Med, F-33076 Bordeaux, France
关键词
extended amygdala; allostasis; opponent process; drug addiction; neuroadaptation;
D O I
10.1146/annurev.psych.59.103006.093548
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
A neurobiological model of the brain emotional systems has been proposed to explain the persistent changes in motivation that are associated with vulnerability to relapse in addiction, and this model may generalize to other psychopathology associated with dysregulated motivational systems. In this framework, addiction is conceptualized as a cycle-of decreased function of brain reward systems and recruitment of antireward systems that progressively worsen, resulting in the compulsive use of drugs. Counteradaptive processes, such as opponent process, that are part of the normal homeostatic limitation of reward function fail to return within the normal homeostatic range and are hypothesized to repeatedly drive the allostatic state. Excessive drug taking thus results in not only the short-term amelioration of the reward deficit but also suppression of the antireward system. However, in the long term, there is worsening of the underlying neurochemical dysregulations that ultimately form an allostatic state (decreased dopamine and opioid peptide function, increased corticotropin-releasing factor activity). This allostatic state is hypothesized to be reflected in a chronic deviation of reward set point that is fueled not only-by dysregulation of reward circuits per se but also by recruitment of brain and hormonal stress responses. Vulnerability to addiction may involve genetic comorbidity and developmental factors at the molecular, cellular, or neurocircuitry levels that sensitize the brain antireward systems.
引用
收藏
页码:29 / 53
页数:29
相关论文
共 124 条
[1]   Transition from moderate to excessive drug intake: Change in hedonic set point [J].
Ahmed, SH ;
Koob, GF .
SCIENCE, 1998, 282 (5387) :298-300
[2]   Neurobiological evidence for hedonic allostasis associated with escalating cocaine use [J].
Ahmed S.H. ;
Kenny P.J. ;
Koob G.F. ;
Markou A. .
Nature Neuroscience, 2002, 5 (7) :625-626
[3]   Persistent increase in the motivation to take heroin in rats with a history of drug escalation [J].
Ahmed, SH ;
Walker, JR ;
Koob, GF .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (04) :413-421
[4]  
Alheid George F., 1995, P495
[5]   Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings From the National Comorbidity Survey [J].
Anthony, James C. ;
Warner, Lynn A. ;
Kessler, Ronald C. .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1994, 2 (03) :244-268
[6]   The bed nucleus of the stria terminalis - A target site for noradrenergic actions in opiate withdrawal [J].
Aston-Jones, G ;
Delfs, JM ;
Druhan, J ;
Zhu, Y .
ADVANCING FROM THE VENTRAL STRIATUM TO THE EXTENDED AMYGDALA: IMPLICATIONS FOR NEUROPSYCHIATRY AND DRUG ABUSE: IN HONOR OF LENNART HEIMER, 1999, 877 :486-498
[7]   CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT [J].
BALDWIN, HA ;
RASSNICK, S ;
RIVIER, J ;
KOOB, GF ;
BRITTON, KT .
PSYCHOPHARMACOLOGY, 1991, 103 (02) :227-232
[8]  
Baumeister RF., 1994, LOSING CONTROL WHY P
[9]   LESIONS OF THE TEGMENTAL PEDUNCULOPONTINE NUCLEUS - EFFECTS ON THE LOCOMOTOR-ACTIVITY INDUCED BY MORPHINE AND AMPHETAMINE [J].
BECHARA, A ;
VANDERKOOY, D .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 42 (01) :9-18
[10]   SPINO(TRIGEMINO) PARABRACHIOHYPOTHALAMIC PATHWAY - ELECTROPHYSIOLOGICAL EVIDENCE FOR AN INVOLVEMENT IN PAIN PROCESSES [J].
BESTER, H ;
MENENDEZ, L ;
BESSON, JM ;
BERNARD, JF .
JOURNAL OF NEUROPHYSIOLOGY, 1995, 73 (02) :568-585